Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis 2025-08-14 12:02
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration 2025-08-13 09:44
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
Intas & Accord signs Agreement to acquire Prothya Biosolutions 2025-08-11 21:41
Everest Medicines to Announce 2025 Interim Results on August 29, 2025 2025-08-11 17:11
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules 2025-08-11 16:30
HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment 2025-08-11 09:00
Brain Navi Biotechnology's NaoTrac performs first surgeries in Spain 2025-08-11 09:00
RemeGen's Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA 2025-08-08 17:50
Codex Genetics Expands Precision Oncology Portfolio with Cxbladder Genomic Urine Tests 2025-08-08 17:45
WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform 2025-08-08 09:30
LabConnect Partners with Kits4Life to Reduce Kit Waste and Advance Sustainable Clinical Trials 2025-08-08 00:40
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration 2025-08-07 08:05
New revolutionary brain tech platform 'ScreenIT' puts smarter concussion care in reach 2025-08-06 06:16
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes 2025-08-05 18:40
MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics 2025-08-04 18:44
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease 2025-08-04 14:05
Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE 2025-08-04 09:28
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics 2025-08-04 08:00
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Received U.S. FDA IND Approval to Initiate a Phase II Clinical Study for Platinum-Resistant Ovarian Cancer 2025-07-31 18:36
1 11 12 13 14 15 264